This public procurement record has 2 releases in its history.

Award

19 Mar 2025 at 00:00

Tender

01 Nov 2024 at 00:00

Summary of the contracting process

The Common Services Agency, more widely known as NHS National Services Scotland (NSS), has completed the public procurement process for the supply of Cytokine Modulators. This tender falls within the health industry category and covers all entities under the National Health Service (Scotland) Act 1978, incorporating any Integrated Joint Boards from the Public Bodies (Joint Working) Scotland Act 2014. Located primarily in the UK region of Scotland (UKM), the process moved to the Award stage as of 19th March 2025, following completion of the tender period that ended on 2nd December 2024. The procurement method used was an open procedure, focusing on procuring goods through multiple frameworks with specific lots such as Etanercept, Infliximab IV and SC, and various concentrations of Methotrexate pens and syringes.

This procurement presents significant business growth opportunities for large pharmaceutical companies providing Cytokine Modulators, with awarded contracts including Biogen Idec Ltd, Sandoz, Pfizer Ltd, and others. Due to the large scale and structured nature of this framework agreement, companies that have robust manufacturing capabilities, valid UK Marketing Authorisations, and compliance with MHRA best practices are well-suited to compete. The framework also encourages involvement with the NHS Scotland's Community Benefits Gateway, aiding in delivering community benefits within Scotland, promoting corporate social responsibility alongside economic opportunities.

How relevant is this notice?

Notice Title

NP47924 Cytokine Modulators

Notice Description

Supply of Cytokine Modulators to NHS Scotland.

Lot Information

Etanercept

Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Infliximab IV

Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Infliximab SC

Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate syringes (25mg/1 ml concentration)

Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate pens (25mg/1ml concentration)

Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate pens (50mg/1 ml concentration)

Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate syringes (50mg/1ml concentration)

Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000781799
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR526310
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
£22,963,164 £10M-£100M
Awards Value
Not specified
Contracts Value
£55,943,000 £10M-£100M

Notice Dates

Publication Date
19 Mar 20251 years ago
Submission Deadline
2 Dec 2024Expired
Future Notice Date
Not specified
Award Date
29 Jan 20251 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
9
Supplier Names

Accord Healthcare Ltd

Biogen Idec Ltd

Celltrion Healthcare United Kingdom Limited

Janssen Cilag Limited

Nordic Pharma Ltd

Pfizer Ltd

Sandoz

Sandoz Ltd

medac Pharma LLP

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...